Results     27-May-22
Announcements
Astrazeneca Pharma India standalone net profit rises 2.57% in the March 2022 quarter
Sales rise 10.32% to Rs 231.96 crore
Net profit of Astrazeneca Pharma India rose 2.57% to Rs 27.98 crore in the quarter ended March 2022 as against Rs 27.28 crore during the previous quarter ended March 2021. Sales rose 10.32% to Rs 231.96 crore in the quarter ended March 2022 as against Rs 210.26 crore during the previous quarter ended March 2021.

For the full year,net profit declined 33.99% to Rs 61.59 crore in the year ended March 2022 as against Rs 93.30 crore during the previous year ended March 2021. Sales declined 0.98% to Rs 805.60 crore in the year ended March 2022 as against Rs 813.56 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales231.96210.26 10 805.60813.56 -1
OPM %16.3619.22 -10.7016.65 -
PBDT41.4342.68 -3 99.98147.22 -32
PBT37.0236.84 0 83.03127.09 -35
NP27.9827.28 3 61.5993.30 -34

Previous News
  Board of Astrazeneca Pharma India recommends final dividend
 ( Corporate News - 28-May-24   09:52 )
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  AstraZeneca Pharma gets DCGI nod for breast cancer drug
 ( Hot Pursuit - 22-Aug-22   11:11 )
  Astrazeneca Pharma India standalone net profit rises 10.17% in the June 2018 quarter
 ( Results - Announcements 15-Aug-18   13:44 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 31-Jan-23   12:07 )
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
  Astrazeneca Pharma India declare Quarterly Result
 ( Corporate News - 16-May-24   14:53 )
  AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets
 ( Hot Pursuit - 28-Nov-22   10:12 )
  Castrol India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 22-Dec-23   12:00 )
  Astrazeneca Pharma India to conduct AGM
 ( Corporate News - 16-Jul-22   17:26 )
  Astrazeneca Pharma India standalone net profit declines 46.08% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:42 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top